Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis

Journal of Internal Medicine

Volumn 260, Issue 3, 2006, Pages 187-191

  Lamprecht, P ^a   Csernok, E ^a   Gross, W L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNITY; EDITORIAL; EFFECTOR CELL; GRANULOMA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; T LYMPHOCYTE SUBPOPULATION; WEGENER GRANULOMATOSIS;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, TUMOR NECROSIS FACTOR; WEGENER GRANULOMATOSIS;

EID: 33747428725     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01698.x     Document Type: Editorial

References (22)

1. Bacon PA. The spectrum of Wegener's granulomatosis and disease relapse. New Engl J Med 2005; 352: 330-2.
2. Sarraf P, Sneller M. Pathogenesis of Wegener's granulomatosis: current concepts. Expert Rev Mol Med 2005; 7: 1-19.
3. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Int Med 1989; 111: 28-40.
4. Jayne D, for the European Vasculitis Study Group (EUVAS). Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001; 13: 48-55.
5. - T-cells are a major source of IFN-γ and TNF-α in Wegener's granulomatosis. Am J Pathol 2002; 160: 1717-24.
6. Grunewald J, Halapi E, Wahlstrom J et al. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood 1998; 92: 3737-44.
7. Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM. Shortening of telomeres: evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int 2003; 63: 2144-51.
8. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999; 103: 885-94.
9. Marinaki S, Kalsch AI, Grimminiger P et al. Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol Dial Transplant 2006; 21: 1825-32.
10. Abdulahad W, Stegeman CA, Van der Geld YM, Doornbosvan der Meer B, Limburg PC, Kallenberg CGM. Functional defect of circulating regulatory CD4 + CD25high T-cells in Wegener's granulomatosis. Ann Rheum Dis 2006; 65 (Suppl. 11): 364.
11. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and longevity of CD4 + CD28null T cells are associated with defects in apoptotic pathways. J Immunol 2000; 165: 6301-7.
12. Giscombe R, Wang XB, Kakoulidou M, Lefvert AK. Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis. J Intern Med 2006; 260: 224-30.
13. Steiner K, Moosig F, Csernok E et al. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis. Clin Exp Immunol 2001; 126: 143-50.
14. Pandiyan P, Gärtner D, Soezeri O, Radbruch A, Schulze-Osthoff K, Brunner-Weinzierl MC. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med 2004; 199: 831-42.
15. Csernok E, Ai M, Gross WL et al. Wegener's autoantigen induces maturation of dendritic cells and licences them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006; 107: 4440-8.
16. Popa ER, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002; 4: 77-9.
17. Jagiello P, Gencik M, Arning L et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114: 468-77.
18. Jagiello P, Aries P, Arning L et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005; 52: 4039-43.
19. Pendergraft WF III, Preston GA, Shah RR et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10: 72-9.
20. Voswinkel J, Mueller A, Kraemer JA et al. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006; 65: 859-64.
21. Mukhtyar C, Luqmani R. Current state of tumor necrosis factor α blockade in Wegener's granulomatosis. Ann Rheum Dis 2005; 64 (Suppl. IV): 31-6.
22. Hellmich B, Lamprecht P, Gross WL. Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol 2006; 18: 25-32.